Literature DB >> 17592131

Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: a possible general mechanism for familial ALS.

Lucia Banci1, Ivano Bertini, Armando Durazo, Stefania Girotto, Edith Butler Gralla, Manuele Martinelli, Joan Selverstone Valentine, Miguela Vieru, Julian P Whitelegge.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder selectively affecting motor neurons; 90% of the total cases are sporadic, but 2% are associated with mutations in the gene coding for the antioxidant enzyme copper-zinc superoxide dismutase (SOD1). The causes of motor neuron death in ALS are poorly understood in general, but for SOD1-linked familial ALS, aberrant oligomerization of SOD1 mutant proteins has been strongly implicated. In this work, we show that wild-type human SOD1, when lacking both its metal ions, forms large, stable, soluble protein oligomers with an average molecular mass of approximately 650 kDa under physiological conditions, i.e., 37 degrees C, pH 7.0, and 100 microM protein concentration. It further is shown here that intermolecular disulfide bonds are formed during oligomerization and that Cys-6 and Cys-111 are implicated in this bonding. The formation of the soluble oligomers was monitored by their ability to enhance the fluorescence of thioflavin T, a benzothiazole dye that increases in fluorescence intensity upon binding to amyloid fibers, and by disruption of this binding upon addition of the chaotropic agent guanidine hydrochloride. Our results suggest a general, unifying picture of SOD1 aggregation that could operate when wild-type or mutant SOD1 proteins lack their metal ions. Although we cannot exclude other mechanisms in SOD1-linked familial ALS, the one proposed here has the strength of explaining how a large and diverse set of SOD1 mutant proteins all could lead to disease through the same mechanism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17592131      PMCID: PMC1899188          DOI: 10.1073/pnas.0704307104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution.

Authors:  Massimo Stefani; Christopher M Dobson
Journal:  J Mol Med (Berl)       Date:  2003-08-27       Impact factor: 4.599

2.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein).

Authors:  J M McCord; I Fridovich
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

Review 3.  Metals ions and neurodegeneration.

Authors:  Francisco Molina-Holgado; Robert C Hider; Alessandra Gaeta; Robert Williams; Paul Francis
Journal:  Biometals       Date:  2007-02-09       Impact factor: 2.949

4.  Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site.

Authors:  Jiou Wang; Guilian Xu; Victoria Gonzales; Michael Coonfield; David Fromholt; Neal G Copeland; Nancy A Jenkins; David R Borchelt
Journal:  Neurobiol Dis       Date:  2002-07       Impact factor: 5.996

5.  Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis.

Authors:  Rishi Rakhit; John P Crow; James R Lepock; Leslie H Kondejewski; Neil R Cashman; Avijit Chakrabartty
Journal:  J Biol Chem       Date:  2004-01-20       Impact factor: 5.157

6.  ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization.

Authors:  Michael DiDonato; Lisa Craig; Mary E Huff; Maria M Thayer; Rosa M F Cardoso; Carey J Kassmann; Terence P Lo; Cami K Bruns; Evan T Powers; Jeffery W Kelly; Elizabeth D Getzoff; John A Tainer
Journal:  J Mol Biol       Date:  2003-09-19       Impact factor: 5.469

7.  Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis.

Authors:  Rishi Rakhit; Patricia Cunningham; Alexandra Furtos-Matei; Sophie Dahan; Xiao-Fei Qi; John P Crow; Neil R Cashman; Leslie H Kondejewski; Avijit Chakrabartty
Journal:  J Biol Chem       Date:  2002-09-27       Impact factor: 5.157

8.  Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis.

Authors:  P Andreas Jonsson; Karin Ernhill; Peter M Andersen; Daniel Bergemalm; Thomas Brännström; Ole Gredal; Peter Nilsson; Stefan L Marklund
Journal:  Brain       Date:  2003-10-08       Impact factor: 13.501

Review 9.  Unraveling the mechanisms involved in motor neuron degeneration in ALS.

Authors:  Lucie I Bruijn; Timothy M Miller; Don W Cleveland
Journal:  Annu Rev Neurosci       Date:  2004       Impact factor: 12.449

10.  A role for intermolecular disulfide bonds in prion diseases?

Authors:  E Welker; W J Wedemeyer; H A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

View more
  105 in total

1.  Nonamyloid aggregates arising from mature copper/zinc superoxide dismutases resemble those observed in amyotrophic lateral sclerosis.

Authors:  Young-Mi Hwang; Peter B Stathopulos; Kristin Dimmick; Hong Yang; Hamid R Badiei; Ming Sze Tong; Jessica A O Rumfeldt; Pu Chen; Vassili Karanassios; Elizabeth M Meiering
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

Review 2.  Aminoacyl tRNA synthetases and their connections to disease.

Authors:  Sang Gyu Park; Paul Schimmel; Sunghoon Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-05       Impact factor: 11.205

3.  Practical considerations over spectral quality in solid state NMR spectroscopy of soluble proteins.

Authors:  Marco Fragai; Claudio Luchinat; Giacomo Parigi; Enrico Ravera
Journal:  J Biomol NMR       Date:  2013-08-30       Impact factor: 2.835

4.  The role of solvent exclusion in the interaction between D124 and the metal site in SOD1: implications for ALS.

Authors:  Raúl Mera-Adasme; Carl-Mikael Suomivuori; Angélica Fierro; Janne Pesonen; Dage Sundholm
Journal:  J Biol Inorg Chem       Date:  2013-09-13       Impact factor: 3.358

5.  Arresting amyloid with coulomb's law: acetylation of ALS-linked SOD1 by aspirin impedes aggregation.

Authors:  Alireza Abdolvahabi; Yunhua Shi; Nicholas R Rhodes; Nathan P Cook; Angel A Martí; Bryan F Shaw
Journal:  Biophys J       Date:  2015-03-10       Impact factor: 4.033

6.  Modifications of superoxide dismutase (SOD1) in human erythrocytes: a possible role in amyotrophic lateral sclerosis.

Authors:  Kyle C Wilcox; Li Zhou; Joshua K Jordon; Yi Huang; Yanbao Yu; Rachel L Redler; Xian Chen; Michael Caplow; Nikolay V Dokholyan
Journal:  J Biol Chem       Date:  2009-03-19       Impact factor: 5.157

7.  Altered thiol chemistry in human amyotrophic lateral sclerosis-linked mutants of superoxide dismutase 1.

Authors:  Carles Solsona; Thomas B Kahn; Carmen L Badilla; Cristina Álvarez-Zaldiernas; Juan Blasi; Julio M Fernandez; Jorge Alegre-Cebollada
Journal:  J Biol Chem       Date:  2014-08-04       Impact factor: 5.157

8.  Metal-free ALS variants of dimeric human Cu,Zn-superoxide dismutase have enhanced populations of monomeric species.

Authors:  Anna-Karin E Svensson; Osman Bilsel; Can Kayatekin; Jessica A Adefusika; Jill A Zitzewitz; C Robert Matthews
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

9.  Loss of metal ions, disulfide reduction and mutations related to familial ALS promote formation of amyloid-like aggregates from superoxide dismutase.

Authors:  Zeynep A Oztug Durer; Jeffrey A Cohlberg; Phong Dinh; Shelby Padua; Krista Ehrenclou; Sean Downes; James K Tan; Yoko Nakano; Christopher J Bowman; Jessica L Hoskins; Chuhee Kwon; Andrew Z Mason; Jorge A Rodriguez; Peter A Doucette; Bryan F Shaw; Joan Selverstone Valentine
Journal:  PLoS One       Date:  2009-03-27       Impact factor: 3.240

10.  Cytosolic superoxide dismutase (SOD1) is critical for tolerating the oxidative stress of zinc deficiency in yeast.

Authors:  Chang-Yi Wu; Janet Steffen; David J Eide
Journal:  PLoS One       Date:  2009-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.